News

Sonja Beach visited Duke Eye Center for a consultation as a last resort in September 2020 after having almost unbearable pain and light sensitivity in her right eye after being treated for an eye i

Duke glaucoma specialist Henry Tseng, MD, PhD discovered an important novel function for a gene called Optineurin through a collaboration with an interdisciplinary team of virologi

Sharon Freedman, MD, professor of ophthalmology and pediatric ophthalmology and strabismus division chief and her colleagues have had a productive year with continued clinical rese

Age-related macular degeneration (AMD) is the leading cause of vision loss in the elderly in the Western World.

Julie A. Woodward, MD, professor of ophthalmology and chief of the oculofacial and reconstructive surgery division continues to be a leader in the field.  

Researchers at Duke Eye Center have identified that Netarsudil™ is particularly effective at treating steroid induced glaucoma. Results of the study were published in eLife in March 2021. 

She believed she could, so she did. 

Duke Eye Center recently established a mobile eye imaging center – a van that has been modified and equipped to screen patients at primary care clinics to identify eye disease.  This advanceme

Advancing research, education and access to eye care across the globe 

One-of-a-kind database created at Duke helps researchers to conduct large-scale, complex diagnostic studies using artificial intelligence (AI) and deep learning models